Anti-HCMV activity by an irreversible p97 inhibitor LC-1310.
Yan WangRuben Soto-AcostaRui DingLiqiang ChenRobert J GeraghtyPublished in: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents (2021)
The AAA+ (ATPase associated with various cellular activities) protein p97, also called valosin-containing protein, is a hexameric ring ATPase and uses ATP hydrolysis to unfold or extract proteins from biological complexes. Many cellular processes are affected by p97 including ER-associated degradation, DNA damage response, cell signaling (NF-κB), cell cycle progression, autophagy, and others. Not surprisingly, with its role in many fundamental cellular processes, p97 function is important for the replication of many viruses. We tested irreversible p97-targeting compounds for their ability to inhibit the replication of multiple viruses compared to the known p97 inhibitors NMS-873 and CB-5083. Our results indicate that overall cellular toxicity for p97 compounds provides a challenge for antivirals targeting p97. However, we identified one compound with sub-micromolar activity against human cytomegalovirus and improved cell viability to provide evidence for the potential of irreversible p97 inhibitors as antivirals.
Keyphrases
- cell cycle
- dna damage response
- oxidative stress
- signaling pathway
- endothelial cells
- cancer therapy
- endoplasmic reticulum
- single cell
- cell therapy
- epstein barr virus
- dna repair
- protein protein
- amino acid
- mass spectrometry
- dna damage
- drug delivery
- high resolution
- anaerobic digestion
- breast cancer cells
- gas chromatography
- tandem mass spectrometry